Skip to content

Extracorporeal Perfusion of Microvascular Free Flaps

Extracorporal Perfusion of Free Flaps in the Head and Neck

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02449525
Enrollment
10
Registered
2015-05-20
Start date
2013-06-30
Completion date
2018-05-31
Last updated
2016-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complication of Perfusion, Perfusion

Brief summary

The perfusion of microvascular free flaps is inevitable for completion of reconstruction in the head and neck area. In some patients microvascular anastomosis is impossible because of arteriosclerotic changes, different oncological interventions, and consecutive vessel depletion at the neck. The aim of the project is to establish an innovative system for extracorporeal perfusion of microvascular free flaps after ingrowth of new vessels from the wound bed have taken place. Afterwards, no further perfusion of the vascular pedicle is required for free flaps to survive and provide functional and aesthetic reconstruction.

Interventions

PROCEDUREPerfusion of flaps by a special bypass system

Free flaps are perfused via a special bypass perfused by a new technique supported by a intermittent perfusion support system.

Sponsors

Technical University of Munich
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Vessel depleted neck * defect in the head and neck area

Exclusion criteria

* active oncological disease * vessels suitable for microvascular anastomosis and reconstruction

Design outcomes

Primary

MeasureTime frame
Perfusion of Free Flap from wound bedTwo Weeks

Countries

Germany

Contacts

Primary ContactKlaus-Dietrich Wolff, Univ.-Prof.
wolff@mkg.med.tum.de0049(0)894140 2921
Backup ContactThomas Mücke, Priv.-Doz.
th.mucke@gmx.de0049(0)894140 2921

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 14, 2026